| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015345611 |
| P356 | DOI | 10.1186/S12885-016-2474-Z |
| P932 | PMC publication ID | 4937612 |
| P698 | PubMed publication ID | 27389279 |
| P50 | author | Wagner José Fávaro | Q38549238 |
| Nelson Durán | Q51584536 | ||
| P2093 | author name string | Rok Romih | |
| Patrick Vianna Garcia | |||
| Fábio Rodrigues Ferreira Seiva | |||
| Alda Maria Macedo | |||
| Alexandre Gabarra de Oliveira | |||
| Amanda Pocol Carniato | |||
| Iseu da Silva Nunes | |||
| Odilon da Silva Nunes | |||
| Wilson de Mello Júnior | |||
| P2860 | cites work | Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 |
| Toll-like receptor signalling | Q24570126 | ||
| TLR signaling pathways | Q24570127 | ||
| Phosphorylation and hsp90 binding mediate heat shock stabilization of p53 | Q28214608 | ||
| IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity | Q29620119 | ||
| VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain | Q30936721 | ||
| Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. | Q31775425 | ||
| Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation | Q33798689 | ||
| The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. | Q33869489 | ||
| Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice | Q33882469 | ||
| ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder | Q34059983 | ||
| Molecular pathogenesis of human hepatocellular carcinoma. | Q34167480 | ||
| Endothelial cell metabolism: parallels and divergences with cancer cell metabolism | Q34228247 | ||
| Nitric oxide-induced apoptosis in tumor cells | Q34305204 | ||
| Regulation of tumor growth by IFN-gamma in cancer immunotherapy. | Q34397096 | ||
| Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action | Q34479375 | ||
| p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase | Q34558437 | ||
| Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. | Q35197371 | ||
| Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer. | Q35853865 | ||
| Recombinant Mycobacterium bovis bacillus Calmette-Guerin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites | Q35946884 | ||
| Bladder Cancer Immunotherapy: BCG and Beyond. | Q36072179 | ||
| Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer | Q36127825 | ||
| Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? | Q36557953 | ||
| Role of neutrophils in BCG immunotherapy for bladder cancer | Q36803793 | ||
| Mutant p53 mediates survival of breast cancer cells | Q37424034 | ||
| VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus. | Q37631627 | ||
| IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors. | Q37937750 | ||
| Expression regulation and function of NLRC5. | Q38088676 | ||
| Toll-like receptors in urothelial cells--targets for cancer immunotherapy | Q38131726 | ||
| Toll-like receptors and prostate cancer | Q38237640 | ||
| Animal models for bladder cancer: The model establishment and evaluation (Review). | Q38383646 | ||
| TNF autovaccination induces self anti-TNF antibodies and inhibits metastasis in a murine melanoma model | Q38797655 | ||
| Interferon-gamma-induced nitric oxide inhibits the proliferation of murine renal cell carcinoma cells | Q39275844 | ||
| Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors | Q39517321 | ||
| IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer | Q39725373 | ||
| The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer. | Q39875256 | ||
| Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis | Q39928245 | ||
| Cross-talk between T cells and innate immune cells is crucial for IFN-gamma-dependent tumor rejection | Q40104696 | ||
| Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression | Q40513415 | ||
| Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects | Q40541175 | ||
| The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee | Q40831782 | ||
| Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. | Q40927961 | ||
| Compartmentalized gene expression of toll-like receptors 2, 4 and 9 in the brain and peripheral lymphoid organs during canine visceral leishmaniasis. | Q41715979 | ||
| Characterization of an aggregated polymer from Penicillium sp. (PB-73 strain). | Q41963642 | ||
| Factors affecting valrubicin response in patients with bacillus Calmette-Guérin-refractory bladder carcinoma in situ | Q42600757 | ||
| Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation | Q42809917 | ||
| Anti-angiogenic activity of triptolide in anaplastic thyroid carcinoma is mediated by targeting vascular endothelial and tumor cells | Q43255562 | ||
| Efficacy and safety of MCNA in patients with nonmuscle invasive bladder cancer at high risk for recurrence and progression after failed treatment with bacillus Calmette-Guérin | Q45004129 | ||
| A central role for S-nitrosylation in apoptosis. | Q46577716 | ||
| Effects of P-MAPA immunomodulator on Toll-like receptor 2, ROS, nitric oxide, MAPKp38 and IKK in PBMC and macrophages from dogs with visceral leishmaniasis. | Q46767190 | ||
| Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer | Q47358850 | ||
| BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: a prospective cohort outcomes study. | Q53565331 | ||
| Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline. | Q53713467 | ||
| Toll-like receptors in normal and malignant human bladders. | Q54602594 | ||
| Recognition and treatment of BCG failure in bladder cancer. | Q54936111 | ||
| Specific Contribution of p19ARF to Nitric Oxide-Dependent Apoptosis | Q57562775 | ||
| p53 Predictive Value for pT1-2 N0 Disease at Radical Cystectomy | Q59649613 | ||
| Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superficial bladder tumors treated with intravesical bacillus Calmette-Guerin | Q60746842 | ||
| Mycobacterium bovis bacille Calmette Guerin infection of human neutrophils induces CXCL8 secretion by MyD88-dependent TLR2 and TLR4 activation | Q62061192 | ||
| Local toxicity patterns associated with intravesical bacillus Calmette-Guérin: a Southwest Oncology Group Study | Q71213938 | ||
| Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 | Q71644976 | ||
| Late effects of intravesical bacillus Calmette-Guérin immunotherapy on bladder mucosa infiltrating lymphocytes: an immunohistochemical study | Q71707909 | ||
| Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma | Q80173159 | ||
| Bacillus Calmette-Guerin mechanism of action: the role of immunity, apoptosis, necrosis and autophagy | Q81296342 | ||
| Enhanced formation of nitric oxide in bladder carcinoma in situ and in BCG treated bladder cancer | Q82730252 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 422 | |
| P577 | publication date | 2016-07-07 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier | |
| P478 | volume | 16 |
| Q99583093 | Calcium supplementation shows a hepatoprotective effect against high-fat diet by regulating oxidative-induced inflammatory response and lipogenesis activity in male rats |
| Q92347062 | P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study |
| Q92153231 | P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study |
| Q48533544 | P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling |
| Q93204275 | Recent clinical trends in Toll-like receptor targeting therapeutics |
Search more.